140667-77-2

Upstream product

• 56624-93-2 ethoxycarbonyl-2 methyl-2 dioxolanne-1,3 
• 140648-61-9 4-Methyl-1-m-tolyl-azetidin-2-one 

Downstream Products

• 140649-38-3 4-Methyl-3-[1-(2-methyl-[1,3]dioxolan-2-yl)-meth-(E)-ylidene]-1-m-tolyl-azetidin-2-one 
• 140649-62-3 4-Methyl-3-[1-(2-methyl-[1,3]dioxolan-2-yl)-meth-(Z)-ylidene]-1-m-tolyl-azetidin-2-one 
• 111390-73-9 4-Methyl-3-[2-oxo-prop-(E)-ylidene]-1-m-tolyl-azetidin-2-one 
• 111390-74-0 4-Methyl-3-[2-oxo-prop-(Z)-ylidene]-1-m-tolyl-azetidin-2-one 
• 140649-14-5 Methanesulfonic acid (S)-(2-methyl-[1,3]dioxolan-2-yl)-((2R,3S)-2-methyl-4-oxo-1-m-tolyl-azetidin-3-yl)-methyl ester 
• 140648-92-6 (3R,4S)-3-[(R)-Hydroxy-(2-methyl-[1,3]dioxolan-2-yl)-methyl]-4-methyl-1-m-tolyl-azetidin-2-one 

Relevant academic research and scientific papers

Synthesis and platelet aggregation inhibitory activities of 3-(2-oxopropylidene)azetidin-2-one derivatives. II

A series of 3-acylidene-4-methylazetidin-2-one derivatives bearing various substituents at the 1-position of the azetidin-2-one ring was synthesized. These compounds were evaluated for platelet aggregation inhibitory activities. Most of the compounds synt